4
Changes in Ownership
HCW Biologics Inc. Filed Acc 0001209191-22-050074
Chief Financial Officer bought 15,000 shares at $2.58 ($38,651)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Byam Rebecca Chief Financial Officer | 2022-09-14 | Purchase | +15,000 | $2.58 | $38,651 | 327,952 | D |
| Open-market purchases · 15,000 sh · avg $2.58 · $38,651 | |||||||
Loading xslF345X03/doc4.xml…